GFPC > Publications GFPC

Publications GFPC

Lung Cancer 2005;47:395-404

Docetaxel and concurrent radiotherapy after two cycles of induction chemotherapy with cisplatin and vinorelbine in patients with locally advanced non-small-cell lung cancer : a phase II trial conducted by the Groupe Français de Pneumo-Cancérologie

Clin Lung Cancer 2005;7(2):114:20

Multicenter phase II trial of carboplatin/vinorelbine in elderly patients with advanced non-small-cell lung cancer-efficacy and impact on quality of life : GFPC study 99-02

Cancer Therapy 2004;2:69-78

Lung cancer chemotherapy practices in French specialized institutions: results of a national survey 

British J Cancer 2004;90:397-402

Economic of the clinical management of lunc cancer in France: an analysis using a Markov Model

Ann Oncol 2002;13:742-7

Phase II randomized multicenter study evaluating a treatment regimen alternating docetaxel and cisplatin-vinorelbine with a cisplatin-vinorelbine control group in patients with stage IV non-small-cell lung cancer: GFPC 97.01 study

Lung Cancer 2002;36:191-8

Phase I trial of gemcitabine and carboplatin in metastatic non-small-cell lung cancer: a Groupe Francais de Pneumo-Cancerologie Study

Ann Oncol 2001;12:59-67

Results of a phase III study of early versus delayed whole brain radiotherapy with concurrent cisplatin and vinorelbine combination in inoperable brain metastasis of non-small-cell lung cancer: Groupe Français de Pneumo-Cancérologie (GFPC)

J Clin Oncol 2001;19(5):1320-5

Phase II Trial of Paclitaxel and Carboplatin in Metastatic Small-Cell Lung Cancer: A Groupe Français de Pneumo-Cancérologie Study

Rev Mal Respir 2000;17:83-9

Efficacité du Docetaxel dans les cancers broncho-pulmonaires non à patites cellules antérieurement traités par une chimiothérapie comportant des sels de platine

Bull Cancer 2000;87(3):253-8

Etude de phase II : docétaxel dans les cancers broncho-pulmonaires non à petites cellules inopérables